RepliCel Receives Canada Approval For Chronic Achilles Tendinosis Clinical Trial

A lot of people who suffer from achilles tendon ruptures also have pre-existing tendinosis.  Although I never had any pain prior to my achilles tendon rupture in 2013, my achilles tendon MRI images showed some pre-existing tendinosis according to the radiologist who analyzed them.

I have therefore been curious about a Canadian company called Replicel, which in its own words “is a regenerative medicine company focused on developing autologous cell therapies that address diseases caused by a deficit of healthy cells required for normal healing and function.

The company is involved in several areas of regenerative medicine, including hair regeneration, skin rejuvenation and tendon repair.  Its tendon repair product is known as RCT-01.

On December 1st 2014, Replicel received Health Canada phase 1/2 clearance to commence clinical trials of RCT-01 in patients with chronic achilles tendinosis.

Below is a video from Replicel about its RCT-01 product and achilles tendinosis: